Raptor Pharmaceutical Corp. raptorpharma.com


Public list: BIO 2016 (619) Pharma Startups (4732) Cancer Therapeutics (1137) Rare Diseases (230)

Raptor Pharmaceutical Corp. is a global biopharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating, and often fatal diseases. The Company develops, manufactures, and commercializes medicines and clinical treatment for neurodegenerative disorders, liver disease, nephropathic cystinosis, non-alcoholic steatohepatitis (NASH), Huntington's Disease (HD), and aldehyde dehydrogenase (ALDH2) deficiency. Raptor's preclinical programs a...Show all

Raptor Pharmaceutical Corp. is a global biopharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating, and often fatal diseases. The Company develops, manufactures, and commercializes...Show all

Company (Acquired)

Phone: 415-408-6200

Fax:

7 Hamilton Landing
Suite 100
Novato, 94949
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Raptor Pharmaceutical Corp. $35.6M Oct 25, 2016
See all 57 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Raptor Pharmaceutical Corp. Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Memory Pharmaceuticals

Montvale, New Jersey, United States
AcquiredMemory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.Login to see details

Biodel

Danbury, Connecticut, United States
IPO / Went publicBiodel Inc. is a biopharmaceutical drug delivery company. Biodel develops drug delivery technologies that increase drug efficacy, enhance drug performance, and make drugs easier for patients to take. This technology is applicable to a wide range of peptides, proteins and other macromolecules. Using this technology, Biodel has developed a drug formulation of recombinant human insulin designed to speed the delivery of insulin into the blood called ViajectTM to treat patients with Type 1 and Type 2...Show allLogin to see details
See all 57 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Fucosidase inhibitors Aug 01, 2016 Apr 24, 2018 Patent
Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof Jun 23, 2015 Jan 30, 2018 Patent
Aerosol fluoroquinolone formulations for improved pharmacokinetics Apr 18, 2016 Aug 01, 2017 Patent
Methods for analyzing cysteamine compositions Jun 17, 2014 Sep 06, 2016 Patent
Aerosol fluoroquinolone formulations for improved pharmacokinetics Jul 17, 2014 May 03, 2016 Patent
See all 32 patents